Coastal Bridge Advisors, LLC Pfizer Inc Transaction History

Coastal Bridge Advisors, LLC

$355 Million
Q2 2024

A detailed history of Coastal Bridge Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 40,201 shares of PFE stock, worth $1.07 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

40,201

Previous 40,201 -0.0%

Holding current value

$1.07 Million

Previous $1.12 Million 0.81%

% of portfolio

0.32%

Previous 0.28%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $167,068 - $191,847	6,453 Added 19.12%	40,201 $1.12 Million
Q4 2023 Feb 15, 2024	BUY	$26.13 - $33.94 $21,139 - $27,457	809 Added 2.46%	33,748 $971,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $23,810 - $27,832	742 Added 2.3%	32,939 $1.09 Million
Q2 2023 Aug 16, 2023	SELL	$36.12 - $41.79 $104,603 - $121,023	-2,896 Reduced 8.25%	32,197 $1.18 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $18,434 - $23,999	-468 Reduced 1.32%	35,093 $1.43 Million
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $70,307 - $91,778	-1,684 Reduced 4.52%	35,561 $1.82 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $100,560 - $122,759	2,298 Added 6.58%	37,245 $1.63 Million
Q2 2022 Nov 15, 2022	SELL	$46.53 - $55.17 $64,164 - $76,079	-1,379 Reduced 3.8%	34,947 $1.83 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $98,317 - $116,574	2,113 Added 6.18%	36,326 $1.91 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $1.37 Million - $1.69 Million	-29,844 Reduced 46.59%	34,213 $1.77 Million
Q4 2021 May 20, 2022	BUY	$41.32 - $61.25 $1.02 Million - $1.51 Million	24,663 Added 62.61%	64,057 $3.12 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $358,740 - $531,772	8,682 Added 28.27%	39,394 $2.33 Million
Q3 2021 May 20, 2022	SELL	$39.25 - $50.42 $221,370 - $284,368	-5,640 Reduced 15.51%	30,712 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $225,962 - $290,267	5,757 Added 18.82%	36,352 $1.56 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $12,532 - $14,197	-349 Reduced 1.13%	30,595 $1.2 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $32,686 - $36,863	976 Added 3.26%	30,944 $1.12 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $153,359 - $195,009	-4,582 Reduced 13.26%	29,968 $1.1 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $36,036 - $42,278	1,135 Added 3.4%	34,550 $1.27 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $9,216 - $11,181	306 Added 0.92%	33,415 $1.09 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $3,838 - $5,484	142 Added 0.43%	33,109 $1.08 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $526 - $597	-16 Reduced 0.05%	32,967 $1.29 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $8,739 - $11,332	269 Added 0.82%	32,983 $1.19 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $839,963 - $943,085	22,714 Added 227.14%	32,714 $1.42 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $834,379 - $936,815	-22,563 Reduced 69.29%	10,000 $1.42 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $4,012 - $4,408	107 Added 0.33%	32,563 $1.38 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $3,693 - $4,210	96 Added 0.3%	32,456 $1.42 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $101,893 - $123,590	2,956 Added 10.05%	32,360 $1.43 Million
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $9,498 - $10,126	288 Added 0.99%	29,404 $1.07 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $77,126 - $89,477	2,417 Added 9.05%	29,116 $1.03 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $77,030 - $81,731	-2,316 Reduced 7.98%	26,699 $973,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $21,452 - $23,631	692 Added 2.44%	29,015 $1.04 Million
Q1 2017 Aug 14, 2017	BUY	N/A	28,323	28,323 $969,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.

Account

Coastal Bridge Advisors, LLC Pfizer Inc Transaction History